semaglutide injection overdose ‘I felt like she was dying’: Mother recounts 7‑year‑old’s GLP-1 GLP-1 Drug Overdose

The convenience gains are real, but the dose adjustments need to be handled carefully to maintain the same level of metabolic benefit and appetite suppression you are accustomed to

As a result, GLP1-RAs have a prolonged duration of action [1,2]

Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury

Pharmacol Rev 2018;70:71246.ArticlePubMed 25

This is why so many patients report feeling a noticeable lift in energy within hours of their first session

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated significant weight loss benefits in clinical trialsparticipants lost an average of 15% body weight over 68 weeks in the STEP trials